Literature DB >> 2075076

Pharmacokinetics and tissue concentrations of cefuroxime.

T B Vree1, Y A Hekster.   

Abstract

Cefuroxime is well-absorbed and distributed over the human body. This review gives a general summary of published information on tissue concentrations of cefuroxime after an intravenous or intramuscular dose of 750 or 1,500 mg of cefuroxime. Tissue concentrations are given for blister fluid, meninges, eyes, respiratory tract, sputum and bronchi, abdominal and urogenital tract, uterine, ovarian and fallopian tube tissue, myometrium, membranes, placenta, puruloid and healthy human milk, bile, prostate, hip and knee bone. Pharmacokinetics are reviewed in patients with impaired kidney function and in pregnancy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2075076     DOI: 10.1007/BF01967830

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  41 in total

1.  Bioavailability of Cefuroxime in Various Sites including Bile, Sputum and Bone.

Authors:  G K Daikos; J Kosmidis; C Stathakis; A Anyfantis; T Plakoutsis; B Papathanassiou
Journal:  Proc R Soc Med       Date:  1977

2.  Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections.

Authors:  M S Edwards; C J Baker; K M Butler; E O Mason; J P Laurent; W R Cheek
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

3.  [Pharmacokinetics of cefuroxime in pregnant women with acute pyelonephritis].

Authors:  Z M Akhtamova; L E Khokholov; V V Dorokhov; S D Voropaeva
Journal:  Antibiot Med Biotekhnol       Date:  1985-02

4.  Pharmacokinetics of cefuroxime in pregnancy.

Authors:  A Philipson; G Stiernstedt
Journal:  Am J Obstet Gynecol       Date:  1982-04-01       Impact factor: 8.661

5.  Bone concentrations of cefuroxime and cefamandole in the femoral head in 96 patients undergoing total hip replacement surgery.

Authors:  D A Leigh; J Marriner; D Nisbet; H D Powell; J C Church; K Wise
Journal:  J Antimicrob Chemother       Date:  1982-04       Impact factor: 5.790

6.  Pelvic tissue levels of cefuroxime.

Authors:  J M Pritchard; M G Elder; M R Kennedy
Journal:  J Infect       Date:  1981-06       Impact factor: 6.072

7.  The absolute bioavailability of oral cefuroxime axetil in male and female volunteers after fasting and after food.

Authors:  P E Williams; S M Harding
Journal:  J Antimicrob Chemother       Date:  1984-02       Impact factor: 5.790

8.  [Clinical studies on cefuroxime axetil in acute mastitis].

Authors:  T Nakamura; I Hashimoto; Y Sawada; J Mikami
Journal:  Jpn J Antibiot       Date:  1987-02

9.  Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing.

Authors:  D K Sommers; M Van Wyk; P E Williams; S M Harding
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

10.  Penetration of cefuroxime and ceftazidime into human lungs.

Authors:  E J Perea; J Ayarra; M C García Iglesias; I García Luque; J Loscertales
Journal:  Chemotherapy       Date:  1988       Impact factor: 2.544

View more
  2 in total

1.  Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin.

Authors:  R Draenert; M Kunzelmann; A Roggenkamp; J Hellers; J R Bogner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-04       Impact factor: 3.267

2.  Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis.

Authors:  Christer Rimmler; Christian Lanckohr; Ceren Akamp; Dagmar Horn; Manfred Fobker; Karsten Wiebe; Bassam Redwan; Bjoern Ellger; Robin Koeck; Georg Hempel
Journal:  Br J Clin Pharmacol       Date:  2019-12-15       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.